TECOGEN INC. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by TECOGEN INC. (OTCQX: TGEN) on January 14, 2025, regarding an event occurring on the same date. The company is incorporated in Delaware and operates from North Billerica, Massachusetts.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, or liquidity metrics. The only specific financial figure disclosed relates to a debt instrument:
- Promissory Note Balance: $500,000 (Principal amount of the note dated September 18, 2024, held by director Earl R. Lewis, III).
Material Changes
The material change reported is an agreement to permit the conversion of the $500,000 promissory note held by Mr. Earl R. Lewis, III, into common stock. Key terms include:
- Conversion Trigger: At the request of Mr. Lewis, provided he is not subject to trading restrictions.
- Conversion Price: Calculated by dividing the outstanding principal and accrued interest by the average closing price per share of the Company's common stock during the thirty-day period prior to the conversion date.
Guidance, Outlook, and Risks
The filing contains no management guidance, forward-looking outlook, or discussion of general business risks. The primary contingency is the potential dilution of existing shareholders should Mr. Lewis elect to convert the debt to equity, dependent on the stock price at the time of conversion.
Investor Verification Checklist
- Verify the current trading status of TECOGEN INC. shares to determine if Mr. Lewis is eligible to convert the note immediately.
- Review the Company's most recent 10-K or 10-Q to assess the impact of a potential $500,000+ equity issuance on total share count and dilution.
- Confirm the exact amount of accrued interest on the September 18, 2024, note to calculate the total conversion value.
- Check for any other outstanding convertible notes or similar agreements with directors or insiders.